SCHEMBL8979233

SCHEMBL8979233

CNN(C)c1ccccc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ESR1 P03372 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACP1 P24666 1/20 0.36
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 5/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2C19 P33261 3/20 0.35
CYP2D6 P10635 3/20 0.35
ALOX15 P16050 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 1/20 0.35
HIF1A Q16665 1/20 0.35
POLQ O75417 1/20 0.35
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30454780 0.79 ACP1 (0.46) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL1768874 0.79 ACP1 (0.46) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL22651898 0.73 RORC (0.38) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL23750133 0.72 ACHE (0.37) ALDH1A1L3MBTL1ESR1SMN1; SMN2GAA
SCHEMBL17479870 0.72 HDAC6 (0.45) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL5539229 0.72 ESR1 (0.39) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL28122138 0.72 ESR1 (0.39) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL2093130 0.71 ESR1 (0.38) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL2093135 0.71 ESR1 (0.38) ALDH1A1TDP1POLBL3MBTL1ESR1
SCHEMBL8981912 0.71 CYP3A4 (0.41) ALDH1A1TDP1LMNAGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds RECQL, QTRT1, DPYD ALDH1A1 467/4885TDP1 1059/4885POLB 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.